{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T07:50:05Z","timestamp":1782978605755,"version":"3.54.5"},"reference-count":86,"publisher":"Public Library of Science (PLoS)","issue":"1","license":[{"start":{"date-parts":[[2011,1,13]],"date-time":"2011-01-13T00:00:00Z","timestamp":1294876800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0016271","type":"journal-article","created":{"date-parts":[[2011,1,13]],"date-time":"2011-01-13T21:39:30Z","timestamp":1294954770000},"page":"e16271","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":43,"title":["Multi-Modal Proteomic Analysis of Retinal Protein Expression Alterations in a Rat Model of Diabetic Retinopathy"],"prefix":"10.1371","volume":"6","author":[{"given":"Heather D.","family":"VanGuilder","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georgina V.","family":"Bixler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lydia","family":"Kutzler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert M.","family":"Brucklacher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah K.","family":"Bronson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scot R.","family":"Kimball","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Willard M.","family":"Freeman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2011,1,13]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"1859","DOI":"10.1016\/j.ophtha.2008.08.023","article-title":"The Wisconsin Epidemiologic Study of Diabetic Retinopathy: XXII the twenty-five-year progression of retinopathy in persons with type 1 diabetes.","volume":"115","author":"R Klein","year":"2008","journal-title":"Ophthalmology"},{"key":"ref2","first-page":"S1","article-title":"The rising global burden of diabetes and its complications: estimates and projections to the year 2010.","volume":"14","author":"AF Amos","year":"1997","journal-title":"Diabet Med"},{"key":"ref3","first-page":"690","article-title":"Preserving human vision: eliminating blindness from diabetes mellitus.","volume":"69","author":"LM Aiello","year":"1998","journal-title":"J Am Optom Assoc"},{"key":"ref4","first-page":"233","article-title":"Risk factors for high-risk proliferative diabetic retinopathy and severe visual loss: Early Treatment Diabetic Retinopathy Study Report #18.","volume":"39","author":"MD Davis","year":"1998","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1159\/000395327","article-title":"Value of electroretinography and dark adaptation as prognostic tools in diabetic retinopathy.","volume":"2","author":"K Frost-Larsen","year":"1981","journal-title":"Dev Ophthalmol"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1111\/j.1755-3768.1983.tb01399.x","article-title":"Contrast sensitivity in evaluation of visual impairment due to diabetes.","volume":"61","author":"L Hyvarinen","year":"1983","journal-title":"Acta Ophthalmol (Copenh)"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1001\/archopht.1985.01050010055018","article-title":"Contrast sensitivity in diabetics with and without background retinopathy.","volume":"103","author":"S Sokol","year":"1985","journal-title":"Arch Ophthalmol"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1007\/BF00400947","article-title":"Presence and further development of retinal dysfunction after 3-year follow up in IDDM patients without angiographically documented vasculopathy.","volume":"37","author":"MA Di Leo","year":"1994","journal-title":"Diabetologia"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1097\/00006982-200603000-00004","article-title":"Intravitreal bevacizumab (Avastin) treatment of proliferative diabetic retinopathy complicated by vitreous hemorrhage.","volume":"26","author":"RF Spaide","year":"2006","journal-title":"Retina"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/S0140-6736(09)62124-3","article-title":"Diabetic retinopathy.","volume":"376","author":"N Cheung","year":"2010","journal-title":"Lancet"},{"key":"ref11","first-page":"3561","article-title":"Altered expression of retinal occludin and glial fibrillary acidic protein in experimental diabetes. The Penn State Retina Research Group.","volume":"41","author":"AJ Barber","year":"2000","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1038\/tpj.2009.60","article-title":"A multistep validation process of biomarkers for preclinical drug development.","volume":"10","author":"WM Freeman","year":"2010","journal-title":"Pharmacogenomics J"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1460-9568.2008.06322.x","article-title":"Diabetes downregulates presynaptic proteins and reduces basal synapsin I phosphorylation in rat retina.","volume":"28","author":"HD VanGuilder","year":"2008","journal-title":"Eur J Neurosci"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/1755-8794-1-26","article-title":"Whole genome assessment of the retinal response to diabetes reveals a progressive neurovascular inflammatory response.","volume":"1","author":"RM Brucklacher","year":"2008","journal-title":"BMC Med Genomics"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1007\/s12177-009-9045-3","article-title":"Transcriptomic comparison of the retina in two mouse models of diabetes.","volume":"2","author":"WM Freeman","year":"2009","journal-title":"J Ocul Biol Dis Infor"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"2516","DOI":"10.1021\/pr800112g","article-title":"Characterization of the vitreous proteome in diabetes without diabetic retinopathy and diabetes with proliferative diabetic retinopathy.","volume":"7","author":"BB Gao","year":"2008","journal-title":"J Proteome Res"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1038\/nm1534","article-title":"Extracellular carbonic anhydrase mediates hemorrhagic retinal and cerebral vascular permeability through prekallikrein activation.","volume":"13","author":"BB Gao","year":"2007","journal-title":"Nat Med"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1007\/s00125-007-0627-y","article-title":"Proteomic analysis of human vitreous fluid by fluorescence-based difference gel electrophoresis (DIGE): a new strategy for identifying potential candidates in the pathogenesis of proliferative diabetic retinopathy.","volume":"50","author":"M Garcia-Ramirez","year":"2007","journal-title":"Diabetologia"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"4203","DOI":"10.1002\/pmic.200700745","article-title":"Profiling of vitreous proteomes from proliferative diabetic retinopathy and nondiabetic patients.","volume":"7","author":"T Kim","year":"2007","journal-title":"Proteomics"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1001\/archopht.126.8.1076","article-title":"Elevation of apolipoprotein A-I and apolipoprotein H levels in the vitreous fluid and overexpression in the retina of diabetic patients.","volume":"126","author":"R Simo","year":"2008","journal-title":"Arch Ophthalmol"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"2633","DOI":"10.1007\/s00125-009-1548-8","article-title":"Interphotoreceptor retinoid-binding protein (IRBP) is downregulated at early stages of diabetic retinopathy.","volume":"52","author":"M Garcia-Ramirez","year":"2009","journal-title":"Diabetologia"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"2636","DOI":"10.1002\/pmic.200600486","article-title":"Proteome map of normal rat retina and comparison with the proteome of diabetic rat retina: new insight in the pathogenesis of diabetic retinopathy.","volume":"7","author":"GG Quin","year":"2007","journal-title":"Proteomics"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1074\/mcp.M800326-MCP200","article-title":"The retinal proteome in experimental diabetic retinopathy: up-regulation of crystallins and reversal by systemic and periocular insulin.","volume":"8","author":"PE Fort","year":"2009","journal-title":"Mol Cell Proteomics"},{"key":"ref24","first-page":"65","article-title":"Application of two-dimensional electrophoresis in the research of retinal proteins of diabetic rat.","volume":"4","author":"S Liu","year":"2007","journal-title":"Cell Mol Immunol"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"5541","DOI":"10.1021\/pr9006415","article-title":"Angiotensin AT1 receptor antagonism ameliorates murine retinal proteome changes induced by diabetes.","volume":"8","author":"BB Gao","year":"2009","journal-title":"J Proteome Res"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1021\/pr050405o","article-title":"Comparative study of three proteomic quantitative methods, DIGE, cICAT, and iTRAQ, using 2D gel- or LC-MALDI TOF\/TOF.","volume":"5","author":"WW Wu","year":"2006","journal-title":"J Proteome Res"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/S0022-1759(00)00238-6","article-title":"Multiplexed particle-based flow cytometric assays.","volume":"243","author":"DA Vignali","year":"2000","journal-title":"J Immunol Methods"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"2071","DOI":"10.1002\/elps.1150181133","article-title":"Difference gel electrophoresis: a single gel method for detecting changes in protein extracts.","volume":"18","author":"M Unlu","year":"1997","journal-title":"Electrophoresis"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"3651","DOI":"10.1002\/pmic.200700316","article-title":"8-plex quantitation of changes in cerebrospinal fluid protein expression in subjects undergoing intravenous immunoglobulin treatment for Alzheimer's disease.","volume":"7","author":"L Choe","year":"2007","journal-title":"Proteomics"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1167\/iovs.04-0860","article-title":"Expression of acute-phase response proteins in retinal Muller cells in diabetes.","volume":"46","author":"C Gerhardinger","year":"2005","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1007\/s12031-007-9010-1","article-title":"Alpha-crystallin protected axons from optic nerve degeneration after crushing in rats.","volume":"35","author":"X Ying","year":"2008","journal-title":"J Mol Neurosci"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.neures.2009.04.006","article-title":"alphaB-crystallin suppresses oxidative stress-induced astrocyte apoptosis by inhibiting caspase-3 activation.","volume":"64","author":"JH Shin","year":"2009","journal-title":"Neurosci Res"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"3869","DOI":"10.1167\/iovs.08-3138","article-title":"The role of alphaA- and alphaB-crystallins in the survival of retinal ganglion cells after optic nerve axotomy.","volume":"50","author":"Y Munemasa","year":"2009","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.preteyeres.2006.10.003","article-title":"Crystallins in the eye: Function and pathology.","volume":"26","author":"UP Andley","year":"2007","journal-title":"Prog Retin Eye Res"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.biocel.2007.10.034","article-title":"The lens epithelium: focus on the expression and function of the alpha-crystallin chaperones.","volume":"40","author":"UP Andley","year":"2008","journal-title":"Int J Biochem Cell Biol"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.mcn.2007.08.016","article-title":"betaA3\/A1-crystallin in astroglial cells regulates retinal vascular remodeling during development.","volume":"37","author":"D Sinha","year":"2008","journal-title":"Mol Cell Neurosci"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.abb.2005.09.021","article-title":"Elevated expression of alphaA- and alphaB-crystallins in streptozotocin-induced diabetic rat.","volume":"444","author":"PA Kumar","year":"2005","journal-title":"Arch Biochem Biophys"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1111\/j.1748-1716.2008.01860.x","article-title":"Effect of medium- and long-chain fatty acid diets on PPAR and SREBP-1 expression and glucose homeostasis in ACBP-overexpressing transgenic rats.","volume":"194","author":"S Oikari","year":"2008","journal-title":"Acta Physiol (Oxf)"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/0024-3205(91)90440-M","article-title":"Diazepam binding inhibitor (DBI): a peptide with multiple biological actions.","volume":"49","author":"E Costa","year":"1991","journal-title":"Life Sci"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1523\/JNEUROSCI.3936-03.2004","article-title":"Activity-dependent expression of acyl-coenzyme a-binding protein in retinal muller glial cells evoked by optokinetic stimulation.","volume":"24","author":"NH Barmack","year":"2004","journal-title":"J Neurosci"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1111\/j.1471-4159.2008.05229.x","article-title":"Acyl coenzyme A-binding protein (ACBP) is phosphorylated and secreted by retinal Muller astrocytes following protein kinase C activation.","volume":"105","author":"Z Qian","year":"2008","journal-title":"J Neurochem"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1042\/bj2650927","article-title":"Diazepam-binding inhibitor: a neuropeptide and\/or an acyl-CoA ester binding protein?","volume":"265","author":"J Knudsen","year":"1990","journal-title":"Biochem J"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1007\/BF01076484","article-title":"The function of acyl-CoA-binding protein (ACBP)\/diazepam binding inhibitor (DBI).","volume":"123","author":"J Knudsen","year":"1993","journal-title":"Mol Cell Biochem"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1016\/S0028-3908(11)80006-7","article-title":"Electrophysiological characterization of diazepam binding inhibitor (DBI) on GABAA receptors.","volume":"30","author":"J Bormann","year":"1991","journal-title":"Neuropharmacology"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"402","DOI":"10.3109\/08923970903468821","article-title":"Diazepam decreases leukocyte-endothelium interactions in situ.","volume":"32","author":"R Lazzarini","year":"2010","journal-title":"Immunopharmacol Immunotoxicol"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/S0002-9440(10)63952-1","article-title":"Leukocyte-mediated endothelial cell injury and death in the diabetic retina.","volume":"158","author":"AM Joussen","year":"2001","journal-title":"Am J Pathol"},{"issue":"Pt 2","key":"ref47","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1042\/bj2770341","article-title":"Induction of acyl-CoA-binding protein and its mRNA in 3T3-L1 cells by insulin during preadipocyte-to-adipocyte differentiation.","volume":"277","author":"HO Hansen","year":"1991","journal-title":"Biochem J"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1677\/JME-09-0176","article-title":"Acute food deprivation reduces expression of diazepam-binding inhibitor, the precursor of the anorexigenic octadecaneuropeptide ODN, in mouse glial cells.","volume":"44","author":"V Compere","year":"2010","journal-title":"J Mol Endocrinol"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/S0925-4773(01)00532-9","article-title":"Sequential expression of annexin A5 in the vasculature and skeletal elements during mouse development.","volume":"109","author":"B Brachvogel","year":"2001","journal-title":"Mech Dev"},{"key":"ref50","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/0306-4522(96)00295-3","article-title":"Preferential localization of annexin V to the axon terminal.","volume":"75","author":"T Gotow","year":"1996","journal-title":"Neuroscience"},{"key":"ref51","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1074\/mcp.M300127-MCP200","article-title":"The human plasma proteome: a nonredundant list developed by combination of four separate sources.","volume":"3","author":"NL Anderson","year":"2004","journal-title":"Mol Cell Proteomics"},{"key":"ref52","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.brainres.2004.10.026","article-title":"Localisation of annexins in the retina of the rainbow trout-light and electron microscopical investigations.","volume":"1032","author":"M Zaunreiter","year":"2005","journal-title":"Brain Res"},{"key":"ref53","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1038\/msb.2009.27","article-title":"Targeted tandem affinity purification of PSD-95 recovers core postsynaptic complexes and schizophrenia susceptibility proteins.","volume":"5","author":"E Fernandez","year":"2009","journal-title":"Mol Syst Biol"},{"key":"ref54","doi-asserted-by":"crossref","first-page":"5396","DOI":"10.1167\/iovs.09-3474","article-title":"Strain-dependent increases in retinal inflammatory proteins and photoreceptor FGF-2 expression in streptozotocin-induced diabetic rats.","volume":"50","author":"SJ Kirwin","year":"2009","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"ref55","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1016\/0026-0495(95)90102-7","article-title":"Regulation of growth factor mRNA levels in the eyes of diabetic rats.","volume":"44","author":"WL Lowe Jr","year":"1995","journal-title":"Metabolism"},{"key":"ref56","doi-asserted-by":"crossref","first-page":"1679","DOI":"10.1523\/JNEUROSCI.16-05-01679.1996","article-title":"Retinal degeneration in transgenic mice with photoreceptor-specific expression of a dominant-negative fibroblast growth factor receptor.","volume":"16","author":"PA Campochiaro","year":"1996","journal-title":"J Neurosci"},{"key":"ref57","doi-asserted-by":"crossref","first-page":"4934","DOI":"10.1167\/iovs.08-2158","article-title":"HMG-CoA reductase inhibitors (statin) prevents retinal neovascularization in a model of oxygen-induced retinopathy.","volume":"50","author":"M Bartoli","year":"2009","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"ref58","doi-asserted-by":"crossref","first-page":"976","DOI":"10.3109\/02713680903249913","article-title":"Enalapril alters expression of key growth factors in experimental diabetic retinopathy.","volume":"34","author":"HW Kim","year":"2009","journal-title":"Curr Eye Res"},{"key":"ref59","doi-asserted-by":"crossref","first-page":"2650","DOI":"10.4049\/jimmunol.180.4.2650","article-title":"Regulation of alternative macrophage activation by galectin-3.","volume":"180","author":"AC MacKinnon","year":"2008","journal-title":"J Immunol"},{"key":"ref60","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1152\/physiolgenomics.90201.2008","article-title":"Serial analysis of the vascular endothelial transcriptome under static and shear stress conditions.","volume":"34","author":"TJ Chu","year":"2008","journal-title":"Physiol Genomics"},{"key":"ref61","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1007\/BF03401604","article-title":"Identification of galectin-3 as a high-affinity binding protein for advanced glycation end products (AGE): a new member of the AGE-receptor complex.","volume":"1","author":"H Vlassara","year":"1995","journal-title":"Mol Med"},{"key":"ref62","doi-asserted-by":"crossref","first-page":"785","DOI":"10.2337\/diabetes.54.3.785","article-title":"Impaired retinal angiogenesis in diabetes: role of advanced glycation end products and galectin-3.","volume":"54","author":"AW Stitt","year":"2005","journal-title":"Diabetes"},{"key":"ref63","doi-asserted-by":"crossref","first-page":"51837","DOI":"10.1155\/2007\/51837","article-title":"Inhibition of advanced glycation and absence of galectin-3 prevent blood-retinal barrier dysfunction during short-term diabetes.","volume":"2007","author":"P Canning","year":"2007","journal-title":"Exp Diabetes Res"},{"key":"ref64","first-page":"156","article-title":"Advanced glycation and retinal pathology during diabetes.","volume":"57","author":"AW Stitt","year":"2005","journal-title":"Pharmacol Rep"},{"key":"ref65","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.2337\/diabetes.49.7.1249","article-title":"The diabetic milieu modulates the advanced glycation end product-receptor complex in the mesangium by inducing or upregulating galectin-3 expression.","volume":"49","author":"G Pugliese","year":"2000","journal-title":"Diabetes"},{"key":"ref66","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1111\/j.1600-065X.2009.00794.x","article-title":"The regulation of inflammation by galectin-3.","volume":"230","author":"NC Henderson","year":"2009","journal-title":"Immunol Rev"},{"key":"ref67","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1007\/BF01970657","article-title":"Protective role of ceruloplasmin in inflammation.","volume":"9","author":"CW Denko","year":"1979","journal-title":"Agents Actions"},{"key":"ref68","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/0031-6989(85)90070-0","article-title":"Role of ceruloplasmin in inflammation: increased serum ceruloplasmin levels during inflammatory conditions and its possible relationship with anti-inflammatory agents.","volume":"17","author":"VK Deshmukh","year":"1985","journal-title":"Pharmacol Res Commun"},{"key":"ref69","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1093\/jn\/117.9.1615","article-title":"Induction of ceruloplasmin synthesis by retinoic acid in rats: influence of dietary copper and vitamin A status.","volume":"117","author":"EF Barber","year":"1987","journal-title":"J Nutr"},{"key":"ref70","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.2337\/diacare.21.9.1525","article-title":"Hyperglycemia is a factor for an increase in serum ceruloplasmin in type 2 diabetes.","volume":"21","author":"M Daimon","year":"1998","journal-title":"Diabetes Care"},{"key":"ref71","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1016\/0026-0495(95)90095-0","article-title":"Elevated plasma ceruloplasmin in insulin-dependent diabetes mellitus: evidence for increased oxidative stress as a variable complication.","volume":"44","author":"J Cunningham","year":"1995","journal-title":"Metabolism"},{"key":"ref72","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1212\/WNL.53.3.619","article-title":"Hereditary ceruloplasmin deficiency increases advanced glycation end products in the brain.","volume":"53","author":"K Tajima","year":"1999","journal-title":"Neurology"},{"key":"ref73","doi-asserted-by":"crossref","first-page":"2319","DOI":"10.1167\/iovs.08-2642","article-title":"Baicalein reduces inflammatory process in a rodent model of diabetic retinopathy.","volume":"50","author":"LP Yang","year":"2009","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"ref74","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.3181\/00379727-232-2311090","article-title":"Effect of endothelin dual receptor antagonist on VEGF levels in streptozotocin-induced diabetic rat retina.","volume":"231","author":"K Masuzawa","year":"2006","journal-title":"Exp Biol Med (Maywood)"},{"key":"ref75","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1096\/fj.01-0707fje","article-title":"Nonsteroidal anti-inflammatory drugs prevent early diabetic retinopathy via TNF-alpha suppression.","volume":"16","author":"AM Joussen","year":"2002","journal-title":"FASEB J"},{"key":"ref76","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.jdiacomp.2008.10.002","article-title":"Resistance of retinal inflammatory mediators to suppress after reinstitution of good glycemic control: novel mechanism for metabolic memory.","volume":"24","author":"PS Chan","year":"2010","journal-title":"J Diabetes Complications"},{"key":"ref77","doi-asserted-by":"crossref","first-page":"4161","DOI":"10.1167\/iovs.04-0633","article-title":"Role of interleukin-1beta in the development of retinopathy in rats: effect of antioxidants.","volume":"45","author":"RA Kowluru","year":"2004","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"ref78","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1001\/archophthalmol.2008.607","article-title":"Metabolic memory in diabetes is true long-term memory.","volume":"127","author":"RN Frank","year":"2009","journal-title":"Arch Ophthalmol"},{"key":"ref79","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.1001\/archopht.126.12.1707","article-title":"Prolonged effect of intensive therapy on the risk of retinopathy complications in patients with type 1 diabetes mellitus: 10 years after the Diabetes Control and Complications Trial.","volume":"126","author":"NH White","year":"2008","journal-title":"Arch Ophthalmol"},{"key":"ref80","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.neuroscience.2008.12.004","article-title":"Cognitive performance and age-related changes in the hippocampal proteome.","volume":"159","author":"WM Freeman","year":"2009","journal-title":"Neuroscience"},{"key":"ref81","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1111\/j.1471-4159.2010.06719.x","article-title":"Aging alters the expression of neurotransmission-regulating proteins in the hippocampal synaptoproteome.","volume":"113","author":"HD VanGuilder","year":"2010","journal-title":"J Neurochem"},{"key":"ref82","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1038\/nbt1329","article-title":"The minimum information about a proteomics experiment (MIAPE).","volume":"25","author":"CF Taylor","year":"2007","journal-title":"Nat Biotechnol"},{"key":"ref83","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1203\/PDR.0b013e3181dceef5","article-title":"Dual-platform proteomics study of plasma biomarkers in pediatric patients undergoing cardiopulmonary bypass.","volume":"67","author":"TM Umstead","year":"2010","journal-title":"Pediatr Res"},{"key":"ref84","doi-asserted-by":"crossref","first-page":"3661","DOI":"10.1021\/pr070492f","article-title":"Nonlinear fitting method for determining local false discovery rates from decoy database searches.","volume":"7","author":"WH Tang","year":"2008","journal-title":"J Proteome Res"},{"key":"ref85","doi-asserted-by":"crossref","first-page":"D885","DOI":"10.1093\/nar\/gkn764","article-title":"NCBI GEO: archive for high-throughput functional genomic data.","volume":"37","author":"T Barrett","year":"2009","journal-title":"Nucleic Acids Res"},{"key":"ref86","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1038\/nrg1749","article-title":"Microarray data analysis: from disarray to consolidation and consensus.","volume":"7","author":"DB Allison","year":"2006","journal-title":"Nat Rev Genet"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0016271","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T19:22:51Z","timestamp":1740856971000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0016271"}},"subtitle":[],"editor":[{"given":"Karl-Wilhelm","family":"Koch","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2011,1,13]]},"references-count":86,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2011,1,13]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0016271","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,1,13]]}}}